Dioscin promotes autophagy by regulating the AMPK-mTOR pathway in ulcerative colitis

Abstract

Background

Dioscin is reported to alleviate the dextran sodium sulfate (DSS)-induced ulcerative colitis (UC) in mice. Autophagy plays an anti-inflammatory role in UC. We herein aimed to explore the biological functions of dioscin in autophagy in UC.

Methods

To explore the effects of dioscin on UC progression, a DSS-induced mouse model of UC was established. Body weight, disease activity index and macroscopic damage index scores were recorded for seven days. Hematoxylin & Eosin (HE) staining was used to stain colon sections and an BX53 microscope was prepared to observe pathological changes. The activities of glutathione, superoxidative dismutase, and malondialdehyde were determined by commercially available kits. Western blotting was performed to measure the protein levels of p-AMPK/AMPK, p-mTOR/mTOR and autophagy-related genes.

Results

The DSS-induced colitis and oxidative stress in mice were ameliorated after dioscin treatment. Dioscin promoted the phosphorylation of AMPK to inhibit mTOR activation and facilitated autophagy in DSS-induced mice model of UC.

Conclusion

Dioscin promotes autophagy by promoting the phosphorylation of AMPK to inhibit mTOR activation in ulcerative colitis.

Keywords:

• Dioscin
• autophagy
• AMPK-mTOR pathway
• ulcerative colitis
• DSS-induced mice model

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The work was supported by Wuhan Municipal Health Commission Fund Project [grant number: WZ21Q16].